Characterization of methadone overdose: clinical considerations and the scientific evidence.
about
QTc interval screening for cardiac risk in methadone treatment of opioid dependenceECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addictsMethadone deaths: risk factors in pain and addicted populations.Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas.Methadone toxicity in a poisoning referral center.Prognostic factors in acute methadone toxicity: a 5-year study.Increasing deaths from opioid analgesics in the United States.Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.The source of methadone in overdose deaths in Western Virginia in 2004The relationship between self-reported substance use and psychiatric symptoms in low-threshold methadone maintenance treatment clients.Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds.Clinical Signs and Symptoms and Laboratory Findings of Methadone Poisoning in Children.Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin usersClinical Presentation and the Outcome of Therapy in a Cohort of Patients with Methadone Toxicity in Iran.Polydrug abuse: a review of opioid and benzodiazepine combination useMethadone induction doses: are our current practices safe?The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines.Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.Prevalence of pulmonary edema among the deceased cases with acute Methadone poisoning: A report from IranMethadone toxicity: comparing tablet and syrup formulations during a decade in an academic poison center of Iran.Risk Factors for Mortality and Endotracheal Intubation after Methadone Intoxication.Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients.Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings.Estimating the risk of fatal arrhythmia in patients in methadone maintenance treatment for heroin addiction.Social and structural barriers for adherence to methadone maintenance treatment among Vietnamese opioid dependence patients.Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness.Sensitive determination of methadone in human serum and urine by dispersive liquid-liquid microextraction based on the solidification of a floating organic droplet followed by HPLC-UV.Interpretation of pharmaceutical drug concentrations in young children's head hair.
P2860
Q24201880-9DE1238C-093E-432C-9D15-5BC1131DE167Q24235379-24096028-1326-4E86-809A-7BBC039CF458Q33742582-3514D2F3-6319-4546-BC3F-F06A0A2247DDQ33781918-3DB162BB-3FC2-4416-8AD6-EB4EBB2959F3Q33828030-F119679D-E446-400B-A7F8-BF2A5582E5FAQ34096542-075DD4D0-D317-459F-AA6C-C513658A058FQ34550465-546D8E0B-23E5-4BEE-96DC-75F8C8EDAB64Q35094562-D00108C2-0744-4955-8DCB-F157AF28920AQ35167353-17182E3E-8884-4C30-969F-C1B04694BD62Q35181435-E5AECC49-2CBE-4D88-9CB2-2E7A073C88CAQ35733030-DC49A542-B2BB-42A5-84E1-CADB688197F8Q35861986-A4EE0F5B-B89A-4250-9F2E-E962CA6314FEQ35875443-A3008B79-E7CC-414F-B45A-ADAD8131BB08Q36176356-94F43F23-BAA4-4BFF-A460-F22ED74A3642Q36266246-40E0C569-23B8-4638-B780-A4A23F13195CQ36587144-E3C4341E-5FCF-4943-81AA-B3AACD45B1E5Q36968245-2A3AE253-ED14-411C-B80E-4605D9308E85Q37189727-BD71D2C3-0A12-4C09-8226-6ECB426D38C7Q37309608-45C62209-7CA7-414D-A7D2-39F4EB3ADC14Q37374756-E67F9445-2A2D-4653-ACA5-2310D174829DQ38131102-933C21F6-5AF0-4B87-9C9B-FB4037B51905Q38572451-A1D6DB87-6FF4-4D46-BD14-09CDE463CA79Q42181796-10D132C5-4125-432E-BC07-7D492831DDB1Q43247687-6DAB3055-D996-4240-9FCF-C8D3DB0B42C5Q45358460-941E240E-45F2-4464-869D-F5883E671927Q47557670-953AEE1C-1885-41BB-B372-C881DD536F8FQ49800710-A7E58D84-6566-46D7-9177-F8ABD9FA06B3Q52307616-B8B08DCE-CB58-4A41-B206-53230061A9B2Q54713727-D6BF538E-E10D-4C32-BD9B-9F6DF6E5CD95
P2860
Characterization of methadone overdose: clinical considerations and the scientific evidence.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Characterization of methadone ...... s and the scientific evidence.
@ast
Characterization of methadone ...... s and the scientific evidence.
@en
Characterization of methadone ...... s and the scientific evidence.
@nl
type
label
Characterization of methadone ...... s and the scientific evidence.
@ast
Characterization of methadone ...... s and the scientific evidence.
@en
Characterization of methadone ...... s and the scientific evidence.
@nl
prefLabel
Characterization of methadone ...... s and the scientific evidence.
@ast
Characterization of methadone ...... s and the scientific evidence.
@en
Characterization of methadone ...... s and the scientific evidence.
@nl
P1476
Characterization of methadone ...... s and the scientific evidence.
@en
P2093
P304
P356
10.1097/00007691-200208000-00001
P577
2002-08-01T00:00:00Z